Leptospira–Host Interaction and Vaccine Development
Leptospira is a stealth pathogen that survives by evading early host immune defenses. This project investigates how Leptospira circumvents Toll-like receptor signaling, resists complement-mediated killing, and escapes phagocytosis by innate immune cells. By identifying immune pathways and bacterial factors involved in immune evasion, we aim to uncover actionable targets for vaccine and diagnostic development.
Protective immunity against leptospirosis is poorly understood. This research explores how Leptospira alters macrophage polarization and dendritic cell function, thereby shaping downstream adaptive immune responses. Understanding these cellular interactions is critical for defining immune correlates of protection and informing rational vaccine design.
Both pathogens and host cells release extracellular vesicles that profoundly influence immune signalling. This project examines the role of Leptospira-derived outer membrane vesicles and host exosomes in immune modulation during infection. We also evaluate their potential as innovative, next-generation vaccine platforms capable of delivering immunogenic components in a physiologically relevant context.
To overcome the limitations of current leptospiral vaccines, we employ CRISPR/Cas9 mediated genome editing to generate rationally attenuated Leptospira strains. By selectively targeting key virulence determinants, this project aims to develop safe and effective live attenuated vaccine candidates that elicit robust and long-lasting immunity.